Company Rasna Therapeutics, Inc. Other OTC
Equities
RASP
US7538881068
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Keeren Shah
DFI | Director of Finance/CFO | 47 | 30/06/16 |
Jules S. Jacob
PRN | Corporate Officer/Principal | - | 30/06/17 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
John Brancaccio
BRD | Director/Board Member | 76 | 31/07/16 |
Willy Simon
CHM | Chairman | 72 | 13/10/20 |
Gary Jacob
BRD | Director/Board Member | 77 | 22/12/20 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 771,811,360 | 114,303,692 ( 14.81 %) | 0 | 14.81 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+16.45% | 122B | |
+21.96% | 116B | |
+25.39% | 27.03B | |
-20.05% | 20.36B | |
-16.28% | 15.91B | |
-15.94% | 16.43B | |
-44.35% | 15.6B | |
+63.91% | 14.94B | |
+2.52% | 13.59B |